Mayne Pharma Group Ltd share price tumbles 7%

Prior to today, year-to-date the Mayne Pharma Group Ltd (ASX: MYX) share price had been one of the best performers on the local share market with an 8% push higher.

However, almost all of these gains were wiped out on Monday when its shares tumbled 7% to finish the day at 69.5 cents.

What happened?

With no notable news out of the pharmaceutical company since its annual general meeting in November of last year, its rise and fall this year has been a bit of a puzzle.

The most likely reason for its shares climbing higher is the rise of industry giant Teva Pharmaceuticals’ share price during the same period.

As Teva is the world’s largest generic drugs company, a sharp rise in its share price was seen by many as a sign that the difficult trading conditions being faced in the industry were over.

Whether that is the case or not only time will tell, but it seems as though some investors are locking in their gains today.

Incidentally, Teva next updates the market with its quarterly update on February 8, around two weeks before Mayne Pharma reports its half-year results.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Motley Fool Staff has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!